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AbstrACt
Introduction Pressure ulcers (PUs) are associated with 
substantial health burden. Patients in intensive care units 
(ICUs) are at high risk for developing PU. In the absence 
of large randomised controlled trials (RCTs) that compare 
commonly known interventions for preventing PU in ICUs, 
uncertainty remains around the best practice strategy 
for PU management in adult ICUs. This study, therefore, 
aims to identify the most effective interventions and 
combinations of interventions that prevent PU in adult 
ICU using systematic review and network meta-analysis 
(NMA).
Methods and analysis We will search for all published 
and unpublished RCTs evaluating interventions to prevent 
PU compared with other PU prevention measures or with 
usual care in adult ICU. The primary outcomes are the 
incidence of PUs and PU severity in critically ill patients 
in ICU. The secondary outcomes include number of 
PUs per patient and intervention-related harms caused 
by the prevention intervention or intervention-related 
harms. All data extraction will be performed by at least 
two independent reviewers on the basis of a priori 
developed extraction form. We will evaluate the risk 
of bias of the included RCTs in accordance with the 
Cochrane Collaboration’s risk of bias tool, and assess the 
quality of evidence using Grading of Recommendations 
Assessment, Development and Evaluation. A standard 
pairwise meta-analysis and a Bayesian NMA will be 
conducted to compare the efficacy of different PU 
prevention interventions. A surface under the cumulative 
ranking curve will be used to rank the probabilities of each 
prevention intervention for various outcomes.
Ethics and dissemination This study will not require 
the ethics approval as it is a review based on published 
studies. The findings of this study will be submitted to a 
peer-reviewed journal for publication. We anticipate that 
the results of the study will provide the evidence to inform 
clinicians and guideline developers on determining the 
best interventions for the prevention of PU in ICU patients.
PrOsPErO registration number CRD42018085562.
IntrOduCtIOn 
Hospital acquired pressure ulcers (HAPUs) 
are a significant global challenge associated 
with considerable physical and economic 
burden.1–3 Critically ill patients in intensive 
care units (ICU) are at high risk of devel-
oping HAPU due to their characteristics such 
as multiple comorbidities, unstable haemody-
namics, bedridden, increased use of medical 
devices and special medications.4–8 Estimates 
suggest that up to 49% of the ICU patients 
developed HAPUs.9–14 
Previous research including systematic 
reviews and meta-analyses have failed to 
reach robust conclusions on the relative 
effectiveness of different PU prevention strat-
egies due to the limitation of not allowing 
for indirect comparisons.6 15–20 For instance, 
a recent systemic review of 25 studies on the 
effectiveness of PU prevention strategies in 
the ICU cautiously recommended a silicone 
foam dressing, however, no single superior 
strategy was identified in the intensive care 
context.20 McInnes and colleagues conducted 
a meta-analysis with aims to assess the effects 
strengths and limitations of this study
 ► To the best of our knowledge, this study will be the 
first network meta-analysis that comprehensively 
explores and compares the effectiveness of various 
pressure ulcer prevention interventions in adult in-
tensive care unit (ICU) patients.
 ► The present study will ensure that both the risk 
of bias and the quality of evidence of the included 
randomised controlled trial is properly assessed by 
Cochrane risk of bias assessment tool and Grading 
of Recommendations Assessment, Development 
and Evaluation,  respectively.
 ► The findings from this study may help guide health-
care providers to select appropriate prevention 
methods which may ultimately lead to a reduction 
in healthcare costs and improved patient outcomes 
in adult ICUs.
 ► Due to the retrospective nature of this study, the 
findings of this study are likely to be influenced by 
the quantity and quality of the studies included.
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of supporting surfaces in preventing PUs. The authors 
selected 53 trials with more than 16 000 participants. They 
found several known surface supporting devices appear 
to have no clear benefits in practice.21 Consequently, a 
variance continues to exist between recommended PU 
preventions and actual practice.22
Network meta-analysis (NMA) is a statistical method-
ology that compares multiple interventions simultaneously 
by analysing studies making different comparisons in the 
same analysis.23 Contrary to the traditional meta-analysis, 
NMA incorporates direct and indirect evidence within 
a network of RCTs and enables comparison of multiple 
intervention and ranking of the interventions that have 
not been studies in a head to head fashion.24 Despite 
that PU prevention programmes encompass a variety 
of measures such as education, training, repositioning, 
nutritional support, moisture management and support 
surfaces,15 17–19 25–27 only the effectiveness of support 
surfaces was recently assessed by an NMA.28Up-to-date, 
no NMA has been conducted to systematically compare 
and rank the efficacy of the available prevention strate-
gies in adult ICU patients, this study is therefore deemed 
a necessity. The objective of the study is to rank the effec-
tiveness of PU prevention interventions in ICUs through 
a systematic review and NMA. The review question is, 
what are the most effective PU prevention interventions 
(or combinations of interventions) compared with usual 
care for reducing the incidence of PU in adult ICUs?
MEthOds And AnAlysIs
Eligibility criteria
Types of settings
Only studies conducted in adult ICUs will be included.
Types of participants
Patients aged 18 years or older in adult ICUs will be 
included. Patients will not be eligible if they have been 
diagnosed with PU prior to their admission to the ICU. 
No further restrictions will be made on participants’ 
gender, ethnicity and nationality.
Types of studies
Only full articles of RCTs reporting comparisons of one 
prevention intervention with another or conventional 
care for adult ICU patients will be included. We will 
exclude editorials, opinion papers, reviews, qualitative 
studies and case reports. Quasiexperimental and non-ex-
perimental such as cohort, case–control and pre–post 
studies will also be excluded.
Types of intervention
We are interested in any intervention aimed at preventing 
PU in adult ICU patients. Both monofactorial and multi-
factorial interventions will be included, such as risk 
assessment, support surfaces, dressings, repositioning 
regiments, nutritional supplementation and educational 
or training programmes.
Comparators
We will make comparisons between the usual care and 
single prevention measure as well as between different 
PU prevention interventions.
Outcome measures
Primary outcomes
1. The incidence of PUs in critically ill patients in ICUs. 
This will be calculated based on the percentage of the 
participants who develop new PUs during the study 
period.29
2. The severity of PUs. This will be classified as per the 
National Pressure Ulcer Advisory Panel (NPUAP), 
European Pressure Ulcer Advisory Panel (EPUAP), 
and Pan Pacific Pressure Injury Alliance (PPPIA) 
Clinical Practice Guidelines.30
Secondary outcomes
1. Number of PUs per patient.
2. Adverse events caused by the prevention intervention 
or intervention-related harms.
The literature search will be limited to English and 
Chinese articles and no date restrictions will be applied. 
We are aware that overlooking non-English and non-Chi-
nese articles may lead to biases and gaps in our under-
standing of the topic. However, the literature has shown 
the dominance of English in international scientific 
publications with almost 80% research findings reported 
in English.31 Considering the dramatic increase in scien-
tific publications in Chinese-language journals,32 encom-
passing both English and Chinese articles may allow us 
to achieve a descent coverage. A draft eligibility form 
(online appendix 1) has been developed based on the 
relevant study.33 This form will be further reviewed by a 
panel of experts comprising librarian, ICU clinical nurse 
specialists, wound care nurse specialists and subsequently 
piloted by the key investigators.
search strategy
‘Pressure ulcer’, ‘pressure sore’, ‘pressure injury’, ‘decu-
bitus’, ‘decubitus ulcers’ , ‘bed sore’, ‘intensive care’ and 
‘critical care’ will be used as keywords or (and) MeSH 
terms. Searches will be undertaken in the following 
electronic databases: EMBASE, PubMed, the Cochrane 
Central Register of Controlled Trials, CINAHL, SinoMED 
to identify published studies. The databases will be 
searched from their inception to 31 January 2019. An 
experienced librarian will be invited to review the selected 
search strategy. A draft search strategy is summarised in 
online appendix 2. We will also contact organisations 
that produce clinical practice guideline of PU manage-
ment (eg, NPUAP,  npuap. org; EPUAP,  epuap. org; PPPIA; 
Chinese Nursing Association; Japanese Society for Pres-
sure Ulcers). In addition, we will manually search for 
the unpublished literature and check references of all 
included trials to ensure relevant articles are covered. 
Experts in the PU prevention and management field 
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will also be contacted via email to locate non-published 
studies.
study selection
All investigators will be properly trained prior to the 
commencement of the data screening. Rayyan online liter-
ature management software (https:// rayyan. qcri. org) 
will also be introduced to screen and manage literature. 
After screening a random sample of 50 citations, Kappa 
test will be used to calculate the inter-observer agreement 
for all studies included. If Kappa value is less than 0.75, a 
second round of training will be implemented. Duplicate 
publications of original research will be excluded. The 
titles and abstracts of identifiable articles will be screened 
independently by two reviewers (YD and FW), to exclude 
reports that clearly do not meet the inclusion criteria. 
The same reviewers will then independently examine full-
text articles to determine eligibility. When disagreements 
arise, the third author (WZ) will be asked to evaluate the 
full text and the discrepancy will be resolved by group 
discussions. Excluded trials and the rationale for exclu-
sion will be recorded. Figure 1 depicts the study selection 
processes in a Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA)34 flow diagram.
data extraction
A rigorous process will be applied to the data extraction. 
First, a draft data extraction form will be developed 
through team discussions. The form will then be pilot 
tested by each member of the team prior to its usage. Two 
reviewers (YD and FW) will extract the data of interest 
independently using the data extraction form, and 
conflicts or disagreements will be resolved by team discus-
sions. The following descriptive data will be extracted: 
country of origin, author(s), year of publication, interven-
tion(s) and comparator(s), sample size, patient charac-
teristics, setting, primary outcomes, secondary outcomes, 
outcome measurements and any adverse events caused by 
the preventive interventions. In case of insufficient infor-
mation, wherever possible, authors of primary studies will 
be contacted by either telephone, email or post to obtain 
missing data. If a study presents incomplete primary 
outcomes it will only be included in the systematic review 
rather than the meta-analysis.
Figure 1 Study selection process. RCT, randomised controlled trial.
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Quality appraisal
Risk of bias appraisal
Cochrane Risk of Bias Assessment Tool will be used to 
appraise the risk of bias.35 This tool includes: (1) random 
sequence generation (selection bias); (2) allocation 
concealment (selection bias); (3) blinding of outcome 
assessors (detection bias); (4) blinding of patients and 
personnel (performance bias); (5) incomplete outcome 
data (attrition bias); (6) selective reporting (reporting 
bias); (7) anything else, ideally prespecified (other bias). 
Authors of the original study will be contacted for more 
information if there are inadequate details of allocation 
concealment and other characteristics of trials. Each item 
will be classified into high risk or unclear risk or low risk 
with respect to the level of risk of bias by two indepen-
dent reviewers (YD and FW). Any discrepancies will be 
resolved by a third reviewer.
Geometry of the network
The available evidence will be presented in a network plot 
to ensure it provides information on the relative effective-
ness of PU prevention measures. The size of the nodes 
will reflect the sample size of each intervention and the 
thickness of edges will be associated with numbers of 
RCTs.
data synthesis and statistical analysis
Pairwise meta-analysis
Data will be synthesised with a pairwise meta-analysis. 
Risk ratio (RR) and 95% CI will be used for dichoto-
mous outcomes, mean differences or standardised mean 
differences (SMDs) with 95% CI will be used for contin-
uous outcomes. We will evaluate clinical and method-
ological heterogeneity through examination of the 
population, methods and interventions of the included 
studies. Heterogeneity across trials will be assessed by 
estimating the variance between studies using the χ2 
test and I2 statistic. For a p value ≥0.1 and I2 ≤50%, no 
significant statistical heterogeneity exists and the Mantel-
Haenszel fixed effect model will be employed; otherwise 
the Mantel-Haenszel random effects model will be used 
(p value <0.1 and I2 >50%). The sources of heterogeneity 
will be explored by sensitivity analyses.36 The potential 
for publication bias will be examined through the Begg’s 
and Egger’s test if more than 10 studies are available. The 
contour-enhanced funnel plot will be obtained addition-
ally to distinguish asymmetry. The pairwise meta-analysis 
will be carried out in Stata V.13.
Evaluation of the transitivity assumption
Transitivity is one of the major assumptions that NMA 
relies upon.24 We will assess the transitivity by checking 
whether time to occurrence of PUs is similar in the 
different RCTs and comparing the distribution of the 
potential modifiers such as age, and the risk scale of PU 
across the different pairwise comparisons.23
network meta-analysis
We will perform Bayesian NMAs to compare the efficacy 
of selected PU prevention interventions. The NMA will 
be conducted in the WinBUGS V.1.43 software (Medical 
Research Council Biostatistics Unit, Cambridge, UK).37 
A complex statistical models will be built by a Bayesian 
software program, the Markov Chains Monte Carlo simu-
lation technique will be used to generate samples. An 
initial burn-in period of 5000 iterations will be set to allow 
convergence, then posterior summaries will be produced 
based on a further 30 000 iterations. Both Kernel density 
and the auto-correlation plots will be used to assess model 
convergence.38 We will calculate the summary RRs or 
SMD for all pairwise comparisons in a league table. The 
ranking probabilities of all prevention interventions for 
each outcome will be estimated via the surface under the 
cumulative ranking curve.39 We will also compare stability 
using the frequentist approach.40
Assessment of inconsistency
The consistency between direct and indirect evidence 
will be assessed by a loop-specific approach within each 
loop of the network. The loop-specific approach sepa-
rates direct evidence from indirect evidence for a specific 
comparison in the loop (inconsistency factor). I2 and its 
95% CI will be used to estimate the consistency within 
the entire network.41 If the inconsistency is identified, 
subgroup analyses and multiple meta-regressions will be 
performed to determine the impact of the mean age of 
the participants, the risk score of PU, the length of ICU 
stay and blinding method on the PU incidence.
rating the confidence in estimates of the effect in nMA
The quality of evidence that influences network estimates 
will be assessed using the Grading of Recommendations 
Assessment, Development and Evaluation.42 On the basis 
of five domains including the study limitations, incon-
sistency, imprecision, indirectness and publication bias, 
the quality of evidence will be classified into one of the 
four levels, including high, moderate, low and very low 
quality.42
Patient and public involvement
Patients and the public were not involved in the concep-
tion and design of this protocol.
Ethics and dissemination
Ethical approval is not required for this study as it does 
not include any interventions with human or animal or 
confidential personal data. The findings of this study 
may assist clinicians and guideline developers in their 
efforts to prevent PU in ICU patients. The procedures 
of the study will be conducted in accordance with the 
PRISMA-compliant guidelines. The findings of the study 
will be reported according to the PRISMA-compliant 
guidelines and submitted to a peer-reviewed journal for 
publication.
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